Characteristics | TKI resistant patients (n = 84) | Patients with optimal response (n = 18) |
---|---|---|
Median age, years | 46 (15–72) | 55 (19–65) |
Gender, n (%) | Â | Â |
 Male | 46 (54.8) | 11 (61.1) |
 Female | 38 (45.2) | 7 (38.9) |
Race, n (%) | Â | Â |
 Malay | 49 (58.3) | 13 (72.2) |
 Chinese | 17 (20.2) | 4 (22.2) |
 Indian | 14 (16.7) | 0 (0) |
 Others | 4 (4.8) | 1 (5.6) |
CML phase, n (%) | Â | Â |
 Chronic phase | 56 (66.7) | 18 (100) |
 Accelerated phase | 18 (21.4) | 0 (0) |
 Blast phase | 10 (11.9) | 0 (0) |